echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > China Disease Control Bulletin: Xi'an Infectious New Crown Examiner was still infected after being vaccinated, the reason has been found!

    China Disease Control Bulletin: Xi'an Infectious New Crown Examiner was still infected after being vaccinated, the reason has been found!

    • Last Update: 2021-05-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On April 20, the " Chinese Center for Disease Control and Prevention Weekly Report (English) " published online an investigation report that a hospital inspector in Xi'an City was still infected with the new crown virus after receiving two doses of COVID-19 vaccine.


    Chinese Center for Disease Control and Prevention Weekly Report (English)

    The reason is that she may have been exposed to environmental conditions carrying the British mutant virus 5 days before the onset of illness.


    The case belongs to a mild patient and was discharged from hospital on April 9.


    On March 17, 2021, this inspector working in the isolation area of ​​a designated hospital for the new crown was diagnosed with new crown pneumonia.


    According to epidemiological investigations, the inspector was likely to be infected while collecting throat swabs for 2 imported cases of the new crown (returning from Uzbekistan) on March 12.


    The examiner diagnosed the day with a body temperature of 37.


    After she became ill, 33 colleagues from the same medical team were immediately transferred to another designated hospital for isolation and observation.


    The report stated that, 14 days after the completion of the two doses of the new crown vaccine, 31 medical staff including the inspectors all showed positive changes in serum new crown antibodies, especially the extremely high serum antibody titer 2 days after the onset of the inspector, indicating that the vaccine was immunized effective.


    The report once again reminds medical staff that the clinical treatment of patients with new coronary pneumonia is a high-risk medical practice.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.